These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24868149)

  • 1. Approaches to improve adherence to pharmacotherapy in patients with schizophrenia.
    Shuler KM
    Patient Prefer Adherence; 2014; 8():701-14. PubMed ID: 24868149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.
    Velligan DI; Sajatovic M; Hatch A; Kramata P; Docherty JP
    Patient Prefer Adherence; 2017; 11():449-468. PubMed ID: 28424542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
    Sun SX; Liu GG; Christensen DB; Fu AZ
    Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse.
    Zhdanava M; Lin D; Lafeuille MH; Ghelerter I; Morrison L; Lefebvre P; Joshi K
    Clin Ther; 2021 Mar; 43(3):535-548. PubMed ID: 33589216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advocacy for the establishment of a comprehensive strategy to reduce the "burden" of schizophrenic disorders].
    Leguay D
    Encephale; 2016 Oct; 42(5):476-483. PubMed ID: 27623121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of barriers to medication adherence in schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
    J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.
    Haddad PM; Brain C; Scott J
    Patient Relat Outcome Meas; 2014; 5():43-62. PubMed ID: 25061342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia.
    Dilla T; Ciudad A; Alvarez M
    Patient Prefer Adherence; 2013; 7():275-84. PubMed ID: 23589681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).
    Brugnoli R; Rapinesi C; Kotzalidis GD; Marcellusi A; Mennini FS; De Filippis S; Carrus D; Ballerini A; Francomano A; Ducci G; Del Casale A; Girardi P
    Riv Psichiatr; 2016; 51(2):47-59. PubMed ID: 27183509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Sep; 16(5):306-24. PubMed ID: 20859108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia through the carers' eyes: results of a European cross-sectional survey.
    Svettini A; Johnson B; Magro C; Saunders J; Jones K; Silk S; Hargarter L; Schreiner A
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):472-83. PubMed ID: 25944551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review.
    Higashi K; Medic G; Littlewood KJ; Diez T; Granström O; De Hert M
    Ther Adv Psychopharmacol; 2013 Aug; 3(4):200-18. PubMed ID: 24167693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.
    Teferra S; Hanlon C; Beyero T; Jacobsson L; Shibre T
    BMC Psychiatry; 2013 Jun; 13():168. PubMed ID: 23773362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey.
    Olivares JM; Thirunavukarasu M; Kulkarni J; Zhang HY; Zhang M; Zhang F
    Neuropsychiatr Dis Treat; 2013; 9():1163-70. PubMed ID: 23976858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and Managing Treatment Adherence in Schizophrenia.
    Dufort A; Zipursky RB
    Clin Schizophr Relat Psychoses; 2019 Jan; ():. PubMed ID: 30605043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.